Quang X. Pham, Chairman, CEO and Interim CFO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 4,126 shares at $3.18 ($13K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Scheduled sale ($13k) by Chairman, CEO and Interim CFO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 3,613 | $11K | 87.6% |
| 2 | $3.16 | 513 | $2K | 12.4% |
| Total | $3.18 avg | 4,126 | $13K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |
| CVKD | SELL | 2026-06-10 | $93K | — | Filing → |